Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Inc (NY: TFX )

229.92 +0.33 (+0.14%)
Streaming Delayed Price Updated: 9:41 AM EDT, Aug 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,469
Open 229.42
Bid (Size) 228.66 (4)
Ask (Size) 230.00 (2)
Prev. Close 229.59
Today's Range 229.42 - 229.92
52wk Range 177.63 - 257.85
Shares Outstanding 46,801,138
Dividend Yield 0.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Beyond The Numbers: 5 Analysts Discuss Teleflex Stock
Via Benzinga
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire

Performance

YTD
-8.19%
-8.19%
1 Month
+4.29%
+4.29%
3 Month
+10.90%
+10.90%
6 Month
-9.03%
-9.03%
1 Year
+0.94%
+0.94%

More News

Read More
Teleflex Reports Second Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
From Teleflex Incorporated
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Teleflex Center for Antimicrobial Protection
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Peering Into Teleflex's Recent Short Interest
Via Benzinga
Expert Ratings For Teleflex
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Via Benzinga
Teleflex Publishes 2023 Global Impact Report
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
From Teleflex Incorporated
Via GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the BofA Securities 2024 Health Care Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
From Teleflex Incorporated
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.